Argan recently saw its share price rise by 41% last month amid several influential events. Most notably, the company's proposal to amend its bylaws to limit the personal liability of officers reflects a significant governance change, while an increase in its equity buyback plan by $25 million could have bolstered investor confidence. Additionally, the appointment of Lisa Larroque Alexander to the board brought new expertise to leadership. These developments came despite a mixed market environment, with broader markets relatively flat as investors awaited significant interest rate decisions and trade discussion outcomes. Overall, these corporate actions could have positively supported Argan's shareholder returns. Argan has 1 weakness we think you should know about.NYSE:AGX Revenue & Expenses Breakdown as at May 2025 We've found 19 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. The recent developments at Argan, including the proposed bylaw amendments and a bolstered equity buyback plan, could potentially fortify investor confidence by reinforcing governance and demonstrating a commitment to shareholder returns. These actions might also enhance Argan's operational continuity and leadership strength with the addition of Lisa Larroque Alexander to the board. In terms of revenue and earnings projections, the increased project backlog and strategic expansions in natural gas and solar energy projects suggest promising growth prospects. However, the focus on large-scale projects introduces execution risks which could impact both revenue and net margins. Over the last five years, Argan's total shareholder return, which factors in both share price and dividends, was a very large 470.76%, signaling substantial value creation over the period. This performance eclipses the broader market and was underpinned by significant earnings growth, as illustrated by a 164.1% increase in earnings over the past year compared to the Construction industry average of 32.2%. In the shorter term, with a price target of US$150, the current share price of US$153.41 represents a minor 2.3% premium, suggesting analysts view the stock as fairly priced at present. Investors should consider this in tandem with the company's robust revenue growth forecast of 11.4% per year, slightly exceeding the US market's 8.4%. Examine Argan's earnings growth report to understand how analysts expect it to perform. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Story Continues Companies discussed in this article include NYSE:AGX. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
Argan (NYSE:AGX) Amends Bylaws To Limit Officers' Liability
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...